Anzeige
Mehr »
Login
Donnerstag, 24.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Jetzt knallt's an der Börse! Diese Aktie hat das Zeug zum Überflieger!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A416MF | ISIN: US09061H4065 | Ticker-Symbol:
NASDAQ
24.04.25
15:30 Uhr
3,630 US-Dollar
-0,060
-1,63 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOMERICA INC Chart 1 Jahr
5-Tage-Chart
BIOMERICA INC 5-Tage-Chart

Aktuelle News zur BIOMERICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiBiomerica, Inc.: United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel Ulcer Test for Detection of H. pylori Infection1
17.04.Biomerica's kidney disease test approved for UAE market3
17.04.Biomerica, Inc.: United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel Kidney Disease Test for Early Detection of Kidney Damage2
16.04.Biomerica Announced 1-for-8 Reverse Stock Split2
BIOMERICA Aktie jetzt für 0€ handeln
16.04.Biomerica stock plummets on 1-for-8 reverse stock split4
16.04.Biomerica, Inc.: Biomerica Announces Reverse Stock Split147IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) ("Biomerica"), a global provider of advanced medical products, today announced that it will implement a 1-for-8 reverse...
► Artikel lesen
16.04.BIOMERICA INC - 8-K, Current Report1
15.04.Biomerica GAAP EPS of -$1.20, revenue of $1.1M2
15.04.Biomerica, Inc.: Biomerica Reports Third Quarter Fiscal 2025 Financial Results162Total Revenue Increases 10% Year-Over-YearDelivers Improved Gross Margins, Achieves Annual Cost Savings Target Early, and Reduces Cash Burn Over 55% IRVINE, Calif., April 15, 2025 (GLOBE NEWSWIRE)...
► Artikel lesen
14.04.BIOMERICA INC - 10-Q, Quarterly Report2
26.02.Biomerica gains EU certification for IBD food intolerance products1
26.02.Biomerica erhält EU-Zertifizierung für Nahrungsmittelunverträglichkeitsprodukte bei CED1
26.02.Biomerica, Inc.: Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis131Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales of the products in the...
► Artikel lesen
19.02.Biomerica, Inc.: Biomerica's inFoods IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal141inFoods IBS Provides Personalized Diet Therapy for Patients Suffering with Irritable Bowel Syndrome (IBS)Research Finds Patients Following a Personalized Diet Therapy Created with inFoods® IBS, Experienced...
► Artikel lesen
16.01.Biomerica Stock Trades 200% Higher After Prostate Screening Test Receives Approval10
16.01.Biomerica's rapid PSA test gains UAE approval7
16.01.Biomerica, Inc.: United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel PSA Screening Test to Detect an Early Sign of Prostate Cancer2
15.01.Biomerica Posts $1.64 Mln In Q2 Revenue, Marks 5% Year-over-Year Growth1
15.01.Biomerica reports Q2 results3
15.01.Biomerica, Inc.: Biomerica Reports Second Quarter Fiscal 2025 Financial Results259- Total Revenue Increases 5% Year-Over-Year - Achieves Sustained Revenue Growth, Improved Gross Margins, and Significant Cost Savings IRVINE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE)...
► Artikel lesen
Seite:  Weiter >>
34 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1